Cipher Mining
CIFR
Hut 8
HUT
TeraWulf
WULF
BTCS Inc
BTCS
Riot Platforms
RIOT
US Stock MarketDetailed Quotes
FDMT 4D Molecular Therapeutics
- 4.740
- -0.130-2.67%
Trading Jan 24 10:41 ET
219.12MMarket Cap-1.66P/E (TTM)
4.880High4.710Low53.53KVolume4.850Open4.870Pre Close255.99KTurnover0.17%Turnover RatioLossP/E (Static)46.23MShares36.25052wk High0.40P/B148.61MFloat Cap4.43052wk Low--Dividend TTM31.35MShs Float55.110Historical High--Div YieldTTM3.49%Amplitude4.430Historical Low4.781Avg Price1Lot Size
About 4D Molecular Therapeutics Company
4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.
Company Profile
SymbolFDMT
Company Name4D Molecular Therapeutics
Issue Price23.00
Founded2013
CEOMr. David Kirn, M.D.
MarketNASDAQ
Employees147
Fiscal Year Ends12-31
Address5858 Horton Street,Suite 455
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-505-2680
Company Executives
- Name
- Position
- Salary
- David Kirn, M.D.
- Director and Chief Executive Officer
- 10.29M
- Uneek Mehra
- Chief Business Officer, Chief Financial Officer and Principal Accounting Officer
- --
- Noriyuki Kasahara, M.D.,PhD
- Chief Scientific Officer
- 488.91K
- Dr. Fariborz Kamal, PhD
- President and Chief Operating Officer
- 4.54M
- Robert Young Kim, M.D.
- Chief Medical Officer
- 3.96M
- Dr. John F. Milligan, PhD
- Executive Chairman of the Board
- 581.44K
- Susannah Gray, M.B.A.
- Independent Director
- 352.62K
- Shawn Cline Tomasello, M.B.A.
- Independent Director
- 345.12K
- Jacob M. Chacko, M.B.A.,M.D.
- Independent Director
- 352.62K
- Nancy Miller-Rich
- Independent Director
- 340.12K
- Dr. Charles P. Theuer, M.D.,PhD
- Independent Director
- 352.62K
- Scott Bizily, J.D.,PhD
- Chief Legal and Corporate Secretary
- --
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.